Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Virpax Pharmaceuticals Inc (VRPX)

Virpax Pharmaceuticals Inc (VRPX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.2508 -0.0492 (-16.40%) 04/22/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.2508 unch (unch) 15:46 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.2350
Day High
0.2800
Open 0.2800
Previous Close 0.3000 0.3000
Volume 4,600 4,600
Avg Vol 306,645 306,645
Stochastic %K 8.43% 8.43%
Weighted Alpha -97.49 -97.49
5-Day Change -0.0092 (-3.54%) -0.0092 (-3.54%)
52-Week Range 0.1300 - 84.7500 0.1300 - 84.7500
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Fundamentals

See More
  • Market Capitalization, $K 373
  • Shares Outstanding, K 1,242
  • Annual Sales, $ 0 K
  • Annual Income, $ -12,070 K
  • EBIT $ -12 M
  • EBITDA $ -12 M
  • 60-Month Beta 1.41
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -123.25
  • Most Recent Earnings $-10.75 on 11/14/24
  • Next Earnings Date 05/12/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr N/A
See More
  • Average Estimate N/A
  • Number of Estimates N/A
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1300 +92.92%
on 04/04/25
Period Open: 2.0700
2.1000 -88.06%
on 03/24/25
-1.8192 (-87.88%)
since 03/21/25
3-Month
0.1300 +92.92%
on 04/04/25
Period Open: 7.1000
11.7500 -97.87%
on 02/14/25
-6.8492 (-96.47%)
since 01/22/25
52-Week
0.1300 +92.92%
on 04/04/25
Period Open: 82.5000
84.7500 -99.70%
on 07/10/24
-82.2492 (-99.70%)
since 04/22/24

Most Recent Stories

More News
Virpax Pharmaceuticals to Present at Sidoti Virtual Investor Conference May 10-11, 2023

Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder,...

VRPX : 0.2508 (-16.40%)
Virpax Pharmaceuticals Engages Dr. Pardeep Gupta to Assist in Development of Company’s Lead Asset, Probudur™

Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder,...

VRPX : 0.2508 (-16.40%)
Virpax Reports on Progress of Envelta™

Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder,...

VRPX : 0.2508 (-16.40%)
Virpax Pharmaceuticals Announces Appointment of Barbara A. Ruskin, Ph.D, J.D. to the Board of Directors

Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder,...

VRPX : 0.2508 (-16.40%)
Virpax Pharmaceuticals Reports 2022 Year-End Results

Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central...

VRPX : 0.2508 (-16.40%)
Virpax Announces Positive Preclinical Toxicology Results in Support of Molecular Envelope Technology (MET)

Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder,...

VRPX : 0.2508 (-16.40%)
Virpax Pharmaceuticals Engages New England Investors to Direct Licensing Strategy for Envelta™ in China

Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, and...

VRPX : 0.2508 (-16.40%)
Virpax Pharmaceuticals to Utilize Dr. Neil K. Singla to Assist in Development of Probudur™

Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, and...

VRPX : 0.2508 (-16.40%)
Virpax Pharmaceuticals Engages Destum Partners to Direct Strategic Global Partnering Efforts

Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central...

VRPX : 0.2508 (-16.40%)
Virpax Pharmaceuticals Engages Dr. Kenneth W. Sommerville and Dr. Lawrence Fried to Assist in Development of NobrXiol™ (formerly VRP324)

Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central...

VRPX : 0.2508 (-16.40%)

Business Summary

Virpax Pharmaceuticals Inc. is a preclinical stage biopharmaceutical company. It is focused on pain management by developing and delivering non-opioid and non-addictive pharmaceutical products using new drug delivery systems and technology. Virpax Pharmaceuticals Inc. is based in WEST CHESTER, PA.

See More

Key Turning Points

3rd Resistance Point 0.3205
2nd Resistance Point 0.3003
1st Resistance Point 0.2755
Last Price 0.2508
1st Support Level 0.2305
2nd Support Level 0.2103
3rd Support Level 0.1855

See More

52-Week High 84.7500
Fibonacci 61.8% 52.4252
Fibonacci 50% 42.4400
Fibonacci 38.2% 32.4548
Last Price 0.2508
52-Week Low 0.1300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro